SAB Biotherapeutics and U.S. Army team up to treat Hantavirus

Human antibodies produced in genetically designed cows can protect against deadly diseases December 3, 2014 SAB Biotherapeutics, Inc. (SAB), a leading biopharmaceutical development company, has teamed up with the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to address the potentially deadly hantavirus using a novel approach to developing protective antibodies against it. Their work, published in the November …